Cardiff Oncology, Inc. revenue
Cardiff Oncology, Inc.'s revenue was $593,000 in fiscal 2025, down 13.2% on the year before. Since fiscal 2011 ($257,696) it has grown at a compound 6.1% a year. Over the last twelve months it was $508,000.
Revenue history
| Fiscal year | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 258 | 450 | 259 | 280 | 313 | 381 | 505 | 378 | 245 | 366 | 359 | 386 | 488 | 683 | 593 | 508 |
| Growth on the year before | — | +74.8% | −42.4% | +8.1% | +11.6% | +21.8% | +32.6% | −25.1% | −35.3% | +49.6% | −1.9% | +7.5% | +26.4% | +40.0% | −13.2% | — |
| Gross profit | — | — | — | 265 | −316 | −1,349 | −1,306 | −219 | 245 | — | — | — | — | — | — | — |
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Cardiff Oncology, Inc. | $508,000 | -7.0% | 7.2% |
| Cervomed Inc. | $331,295 | -95.7% | -52.7% |
| Medicinova Inc | $920,481 | 875.7% | — |
| Shattuck Labs, Inc. | $1.0m | -66.6% | 5.2% |
| Longeveron Inc. | $1.2m | -42.7% | 10.4% |
| Clene Inc. | $197,000 | -31.1% | -36.9% |
Compare with peers
- Cervomed Inc. revenue
- Medicinova Inc revenue
- Shattuck Labs, Inc. revenue
- Longeveron Inc. revenue
- Clene Inc. revenue
Head to head: CRDF vs CRVOCRDF vs MNOVCRDF vs STTK
More: Biotechnology stocks compared, Health Care sector, rankings of US companies